+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Healthcare Contract Research Organizations Services Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Service Type; Therapeutic Indication; End User; and Geography

  • ID: 5129066
  • Report
  • June 2020
  • Region: Global
  • 223 pages
  • The Insight Partners

FEATURED COMPANIES

  • Icon Plc.
  • IQVIA Inc.
  • Medpace
  • PPD Inc
  • Pra Health Sciences
  • Syneos Health
The global healthcare contract research organizations (CRO) services market is expected to reach US$ 87, 859.08 million by 2027 from US$ 43, 208.57 million in 2019. The market is estimated to grow with a CAGR of 9.5% from 2020 to 2027. The increasing expenditure in R&D and outsourcing activities, and rising number of clinical trials are the major factors driving the growth of the healthcare contract research organizations (CRO) services market. However, the dearth of skilled professionals is hindering the growth of the market.

Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments. Additionally, several companies invest extensively in R&D activities to develop different therapeutic applications with strong medical and commercial potential. According to a data published by European Federation of Pharmaceutical Industries and Associations, in 2018, Europe-based pharmaceutical companies invested about US$ 42, 348.4 million for R&D. Additionally, R&D spending by biopharmaceutical companies has increased over the years. For instance, according to a study published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of biopharmaceutical companies grew from US$ 49.6 billion in 2012 to US$ 79.6 billion in 2018. Such massive investments in R&Ds are likely to drive the contract research organization services market during the forecast period.

Contract research organizations assist the sponsor companies in terms of research, development, and commercialization of new therapeutic products, especially in pharmaceutical, biopharmaceutical, and medical device industries. Factors such as increasing cost of research and development, increasing complexity of clinical trials, and emphasis on cost optimization are compelling the companies to outsource research activities.

The global healthcare contract research organizations (CRO) services market is segmented on the basis of service type, therapeutic indication, and end user. Based on service type, the market is segmented into early phase development, laboratory services, consulting services, and clinical research services. The clinical research services segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR in the market during the forecast period. Based on therapeutic indication, the healthcare contract research organizations (CRO) services market is segmented into oncology, infectious diseases, immunological disorders, respiratory diseases, cardiovascular diseases, neurological disorders, and others. On the basis of end user, the healthcare contract research organizations (CRO) services market has been segmented into medical device companies, pharmaceutical and biopharmaceutical companies, and others (academic institutes).

Monash Institute of Pharmaceutical Sciences, World Health Organization (WHO), Australian Research Council, European Medical Association, World Trade Organization, and Pharmaceutical Research and Manufacturers of America, and European Federation of Pharmaceuticals Industries Associations are among the essential secondary sources referred to while preparing this report.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the healthcare contract research organizations (CRO) services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global healthcare contract research organizations (CRO) services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Icon Plc.
  • IQVIA Inc.
  • Medpace
  • PPD Inc
  • Pra Health Sciences
  • Syneos Health
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Healthcare Contract Research Organizations (CRO) Services Market - By Service Type
1.3.2 Global Healthcare Contract Research Organizations (CRO) Services Market - By Therapeutic Indication
1.3.3 Global Healthcare Contract Research Organizations (CRO) Services Market - By End User
1.3.4 Global Healthcare Contract Research Organizations (CRO) Services Market - By Geography

2. Healthcare Contract Research Organizations (CRO) Services Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Healthcare Contract Research Organizations (CRO) Services Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America- PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion

5. Healthcare Contract Research Organizations (CRO) Services Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Expenditure in R&D and Outsourcing Activities
5.1.2 Rising Number of Clinical Trials
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Rising Biosimilars and Biologics Market
5.4 Future Trends
5.4.1 Globalization of Clinical Studies
5.5 Impact Analysis

6. Healthcare Contract Research Organizations (CRO) Services Market - Global Analysis
6.1 Global Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecast And Analysis
6.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Healthcare Contract Research Organizations (CRO) Services Market Analysis - By Service Type
7.1 Overview
7.2 Healthcare Contract Research Organizations (CRO) Services Market Revenue Share, by Service Type (2019 and 2027)
7.3 Early Phase Development
7.3.1 Overview
7.3.2 Early Phase Development: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Discovery Studies
7.3.3.1 Overview
7.3.3.2 Discovery Studies: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Chemistry, Manufacturing, and Control
7.3.4.1 Overview
7.3.4.2 Chemistry, Manufacturing, and Control: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Pre-Clinical Services
7.3.5.1 Overview
7.3.5.2 Pre-Clinical Services: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Laboratory Services
7.4.1 Overview
7.4.2 Laboratory Services: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Bio-analytical Testing
7.4.3.1 Overview
7.4.3.2 Bio-analytical Testing: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Analytical Testing
7.4.4.1 Overview
7.4.4.2 Analytical Testing: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Consulting Services
7.5.1 Overview
7.5.2 Consulting Services: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Clinical Research Services
7.6.1 Overview
7.6.2 Clinical Research Services: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.6.3 Phase I
7.6.3.1 Overview
7.6.3.2 Phase I: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.6.4 Phase II
7.6.4.1 Overview
7.6.4.2 Phase II: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.6.5 Phase III
7.6.5.1 Overview
7.6.5.2 Phase III: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
7.6.6 Phase IV
7.6.6.1 Overview
7.6.6.2 Phase IV: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)

8. Healthcare Contract Research Organizations (CRO) Services Market- By Therapeutic Application
8.1 Overview
8.2 Healthcare Contract Research Organizations (CRO) Services Market Share, by Therapeutic Application, 2019 and 2027 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Healthcare Contract Research Organizations (CRO) Services Market- Revenue and Forecast to 2027 (USD Million)
8.4 Infectious Diseases
8.4.1 Overview
8.4.2 Infectious Diseases: Healthcare Contract Research Organizations (CRO) Services Market- Revenue and Forecast to 2027 (USD Million)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Cardiovascular Disease: Healthcare Contract Research Organizations (CRO) Services Market- Revenue and Forecast to 2027 (USD Million)
8.6 Respiratory Diseases
8.6.1 Overview
8.6.2 Respiratory Diseases: Healthcare Contract Research Organizations (CRO) Services Market- Revenue and Forecast to 2027 (USD Million)
8.7 Neurological Disorders
8.7.1 Overview
8.7.2 Neurological Disorders: Healthcare Contract Research Organizations (CRO) Services Market- Revenue and Forecast to 2027 (USD Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Healthcare Contract Research Organizations (CRO) Services Market- Revenue and Forecast to 2027 (USD Million)

9. Global Healthcare Contract Research Organizations (CRO) Services Market Analysis - by End User
9.1 Overview
9.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By End User 2019 & 2027 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.4 Pharmaceutical and Biopharmaceutical Companies: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Medical Device Companies
9.5.1 Overview
9.6 Medical Device Companies: Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Others (Academic Institutes)
9.7.1 Overview
9.8 Others (Academic Institutes): Healthcare Contract Research Organizations (CRO) Services Market - Revenue and Forecast to 2027 (US$ Million)
Note: Product cover images may vary from those shown
  • Charles River Laboratories Inc.
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Icon Plc.
  • Pra Health Sciences
  • Syneos Health
  • Medpace
  • Wuxi Apptec
  • PPD Inc
Note: Product cover images may vary from those shown
Adroll
adroll